Jonakayem Pharma Formulation (OPC) Pvt. Ltd.
NATEGLINIDE

NATEGLINIDE

Send Inquiry
Product: NATEGLINIDE
Formulary: Generic Formulary
Category: Diabetes
Sub Group: ORAL ANTIDIABETICS & RELATED DRUGS
Dosages: 60 MG/120 mg
Unit of Packing: Tablets
In treatment of: treatment of type Diabetes Mellitus

Adverse Effects: 

  • Flu like symptoms
  • Dizziness
  • Arthralgia
  • Weight gain
  • Nausea
  • Diarrhoea
  • Back pain
  • Increased uric acid
  • Bronchitis
  • Sinusitis
  • Upper respiratory tract infections
  • Accidental injuries
  • Mild hypoglycaemia

Contraiindication: 

  • Hypersensitivity to the drug 
  • Type-1 diabetes mellitus
  • Diabetic ketoacidosis

Special Precaution: 

  • Hepatic impairment
  • Malnourished and deliberate individuals
  • After severe exercise
  • Along with alcohol
  • Along with other glucose lowering drugs
  • Loss of control of blood glucose may occur with drug when patient is exposed to stress such as fever, trauma, infection, or surgery. In such situations stop the Nateglinide and administer insulin
  • Trauma
  • Coma
  • Myocardial infarction
  • Adrenal insufficiency
  • Pituitary insufficiency

Interaction: Nsaids, salicylates, MAOIs, and non selective beta-adrenergic blocking agents: May potentiate the hypoglycaemic effects. Thiazides, corticosteroids, thyroxine and sympathomimetics: May reduce the hypoglycaemic effects.

Servings:Oral: Starts with 60mg thrice daily; taken 10 to 30 minutes before each main meals. Increases the dose based on patient`s response. Maximum dose: 180mg thrice daily